Question

Efficacy of ponatinib after multiple lines of therapy for chronic myeloid leukemia

Answer 1

Efficacy of Ponatinib after Multiple Lines of Therapy for Chronic Myeloid Leukemia. Background: Ponatinib, a third-generation pan-tyrosine kinase inhibitor (TKI), was found to be effective in heavily pretreated patients (pts) with chronic myeloid leukemia (CML).